Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Brandi

Showing results (11-20 of 246) with videos related to

Pageof 25
Sort By:
Expert Review of Gastroenterology & Hepatology|December 14, 2020
BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of careAlessandro Rizzo, Giovanni Brandi
Expert Opinion on Investigational Drugs|March 8, 2021
A foreword on biliary tract cancers: emerging treatments, drug targets, and fundamental knowledge gapsAlessandro Rizzo, Giovanni Brandi
JCO Precision Oncology|March 16, 2022
FGFR Inhibitors in Cholangiocarcinoma: A Real-World Experience at a Tertiary CenterAlessandro Rizzo, Giovanni Brandi
Acta Oncologica (Stockholm, Sweden)|March 7, 2022
Radiofrequency ablation, radiation therapy, transarterial chemoembolization, and yttrium 90: no differences for local treatment of liver cancer?Alessandro Rizzo, Giovanni Brandi
European Journal of Cancer (Oxford, England : 1990)|July 25, 2022
Letter re: "Long-term effectiveness of empiric cardio-protection in patients receiving cardiotoxic chemotherapies: A systematic review and Bayesian network meta-analysis"Alessandro Rizzo, Giovanni Brandi
Cells|February 16, 2020
Asbestos and Intrahepatic CholangiocarcinomaGiovanni Brandi, Simona Tavolari
Cancer Treatment and Research Communications|February 16, 2021
Adjuvant systemic treatment in resected biliary tract cancer: State of the art, controversies, and future directionsAlessandro Rizzo, Giovanni Brandi
Medicina (Kaunas, Lithuania)|March 3, 2021
Novel Targeted Therapies for Advanced CholangiocarcinomaAlessandro Rizzo, Giovanni Brandi
Cancer Treatment and Research Communications|March 23, 2021
Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature reviewAlessandro Rizzo, Giovanni Brandi
International Journal of Molecular Sciences|October 26, 2024
Hepatocellular Carcinoma Immunotherapy: Predictors of Response, Issues, and ChallengesAlessandro Rizzo, Oronzo Brunetti, Giovanni Brandi
Pageof 25

Showing results (11-20 of 246) with videos related to

Sort By:
Pageof 25
Expert Review of Gastroenterology & Hepatology|December 14, 2020
BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of careAlessandro Rizzo, Giovanni Brandi
Expert Opinion on Investigational Drugs|March 8, 2021
A foreword on biliary tract cancers: emerging treatments, drug targets, and fundamental knowledge gapsAlessandro Rizzo, Giovanni Brandi
JCO Precision Oncology|March 16, 2022
FGFR Inhibitors in Cholangiocarcinoma: A Real-World Experience at a Tertiary CenterAlessandro Rizzo, Giovanni Brandi
Acta Oncologica (Stockholm, Sweden)|March 7, 2022
Radiofrequency ablation, radiation therapy, transarterial chemoembolization, and yttrium 90: no differences for local treatment of liver cancer?Alessandro Rizzo, Giovanni Brandi
European Journal of Cancer (Oxford, England : 1990)|July 25, 2022
Letter re: "Long-term effectiveness of empiric cardio-protection in patients receiving cardiotoxic chemotherapies: A systematic review and Bayesian network meta-analysis"Alessandro Rizzo, Giovanni Brandi
Cells|February 16, 2020
Asbestos and Intrahepatic CholangiocarcinomaGiovanni Brandi, Simona Tavolari
Cancer Treatment and Research Communications|February 16, 2021
Adjuvant systemic treatment in resected biliary tract cancer: State of the art, controversies, and future directionsAlessandro Rizzo, Giovanni Brandi
Medicina (Kaunas, Lithuania)|March 3, 2021
Novel Targeted Therapies for Advanced CholangiocarcinomaAlessandro Rizzo, Giovanni Brandi
Cancer Treatment and Research Communications|March 23, 2021
Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature reviewAlessandro Rizzo, Giovanni Brandi
International Journal of Molecular Sciences|October 26, 2024
Hepatocellular Carcinoma Immunotherapy: Predictors of Response, Issues, and ChallengesAlessandro Rizzo, Oronzo Brunetti, Giovanni Brandi
Pageof 25